Fredun Pharmaceuticals Ltd

Fredun Pharmaceuticals Q2 FY27 Results: Net Profit ₹18.6 Cr, Up 97.9% YoY

Fredun Pharmaceuticals Ltd reported revenue from operations of ₹265.9 Cr (+85.2% YoY) and net profit of ₹18.6 Cr (+97.9% YoY) for Q2 FY27.

Key figure

Net profit ₹18.6 Cr · +97.9% YoY

Fredun Pharmaceuticals Q1 FY27 Results: Net Profit ₹13.1 Cr, Up 92.6% YoY

Fredun Pharmaceuticals Ltd reported revenue from operations of ₹227.8 Cr (+90.8% YoY) and net profit of ₹13.1 Cr (+92.6% YoY) for Q1 FY27.

Key figure

Net profit ₹13.1 Cr · +92.6% YoY

Fredun Pharmaceuticals Financial Results

Fredun Pharmaceuticals reported audited FY26 financial results and recommended a 7% final dividend. The board also approved a 2:1 bonus share issue and increased authorized capital.

Value

₹0.38 Cr

Fredun Pharmaceuticals Q4 FY26 Results: Net Profit ₹10.8 Cr, Up 80.0% YoY

Fredun Pharmaceuticals Ltd reported revenue from operations of ₹210.4 Cr (+27.2% YoY) and net profit of ₹10.8 Cr (+80.0% YoY) for Q4 FY26.

Key figure

Net profit ₹10.8 Cr · +80.0% YoY

Fredun Pharmaceuticals Financial Results

Fredun Pharmaceuticals approved FY2026 audited financial results and recommended a 7% final dividend. The board also proposed a 2:1 bonus share issue and increased authorized capital.